Consensus Apontis Pharma AG

Equities

Market Closed - Xetra Other stock markets 16:36:27 17/05/2024 BST			5-day change	1st Jan Change
9.04 ^EUR	-2.59%		+3.20%	+90.32%

04-05	Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications	MT
03-28	Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI

77fb15547f.KZab7voFOFjBcgpkikWlM6dVJtQCKyyhBTosMShd1po.RtXdj5BAVRqTAm805QrcBfEeX4VOXGLubQh2RW0z4uhF1dGosT1oLqYBPg~922339c1b2c8dc66c502be1fdc0f8613

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.04 EUR

Average target price

17.5 EUR

Spread / Average Target

+93.58%

High Price Target

20 EUR

Spread / Highest target

+121.24%

Low Price Target

16 EUR

Spread / Lowest Target

+76.99%

Trading Rating

Investor Rating

ESG Refinitiv